Join Our Mailing List Today!

NOTICE: Online ordering will be disabled 1/27-2/3. Learn More.

OPEN ACCESS: Zhang, Wanqiu et al. (2023) SRRM2 is a target for the immunotherapy of AML with rationally designed CAR-T cells. ResearchGate.

We're sorry, an error has occurred while generating this content.
Categories: Publications
© 2024 FUJIFILM Irvine Scientific. All rights reserved.